Sanofi Finds Contaminant In Heparin Batch
This article was originally published in PharmAsia News
Executive Summary
Sanofi-Aventis of France became the latest drug maker to announce it had discovered a contaminant in its blood thinner heparin. Sanofi said it found amounts of impurity in its Lovenox (enoxapirin). The company said there was no evidence of more allergic reactions than usual with the tainted batch, discovered in the U.K. Sanofi guaranteed batches produced after April 1 were pure. (Click here for more - a subscription may be required